A highly effective atypical antipsychotic reserved for treatment-resistant schizophrenia due to its risk of agranulocytosis, a potentially fatal blood disorder. Requires regular blood monitoring.
Developed by Sandoz (now Novartis) in the 1960s, named for its chemical structure as a dibenzodiazepine compound. The '-ine' suffix is standard for nitrogen-containing pharmaceutical compounds.
Try Another Word